These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 9591629)
41. Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade. Ino Y; Silver JS; Blazejewski L; Nishikawa R; Matsutani M; von Deimling A; Louis DN J Neuropathol Exp Neurol; 1999 Aug; 58(8):881-5. PubMed ID: 10446812 [TBL] [Abstract][Full Text] [Related]
42. Deletion mapping of chromosome 10 in human glioma. Sonoda Y; Murakami Y; Tominaga T; Kayama T; Yoshimoto T; Sekiya T Jpn J Cancer Res; 1996 Apr; 87(4):363-7. PubMed ID: 8641967 [TBL] [Abstract][Full Text] [Related]
43. Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts. Schmidt EE; Ichimura K; Goike HM; Moshref A; Liu L; Collins VP J Neuropathol Exp Neurol; 1999 Nov; 58(11):1170-83. PubMed ID: 10560660 [TBL] [Abstract][Full Text] [Related]
44. Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas. Fujisawa H; Reis RM; Nakamura M; Colella S; Yonekawa Y; Kleihues P; Ohgaki H Lab Invest; 2000 Jan; 80(1):65-72. PubMed ID: 10653004 [TBL] [Abstract][Full Text] [Related]
45. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma. Ittmann MM Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052 [TBL] [Abstract][Full Text] [Related]
46. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas. Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743 [TBL] [Abstract][Full Text] [Related]
47. A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression. Oskam NT; Bijleveld EH; Hulsebos TJ Int J Cancer; 2000 Feb; 85(3):336-9. PubMed ID: 10652423 [TBL] [Abstract][Full Text] [Related]
48. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411 [TBL] [Abstract][Full Text] [Related]
49. Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer. Trybus TM; Burgess AC; Wojno KJ; Glover TW; Macoska JA Cancer Res; 1996 May; 56(10):2263-7. PubMed ID: 8625295 [TBL] [Abstract][Full Text] [Related]
50. Loss of constitutional heterozygosity in human astrocytomas. Van de Kelft E; De Boulle K; Willems P; Martin JJ; Selosse P; Van der Auwera B Acta Neurochir (Wien); 1992; 117(3-4):172-7. PubMed ID: 1357919 [TBL] [Abstract][Full Text] [Related]
51. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Karlbom AE; James CD; Boethius J; Cavenee WK; Collins VP; Nordenskjöld M; Larsson C Hum Genet; 1993 Sep; 92(2):169-74. PubMed ID: 8370584 [TBL] [Abstract][Full Text] [Related]
52. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307 [TBL] [Abstract][Full Text] [Related]
53. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity. Mavros A; Hahn M; Wieland I; Koy S; Koufaki ON; Strelocke K; Koch R; Haroske G; Schackert HK; Eckelt U J Oral Pathol Med; 2002 May; 31(5):270-6. PubMed ID: 12110043 [TBL] [Abstract][Full Text] [Related]
54. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308 [TBL] [Abstract][Full Text] [Related]
55. Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials. Brat DJ; Seiferheld WF; Perry A; Hammond EH; Murray KJ; Schulsinger AR; Mehta MP; Curran WJ; Neuro Oncol; 2004 Apr; 6(2):96-103. PubMed ID: 15134623 [TBL] [Abstract][Full Text] [Related]
57. New deletion in low-grade oligodendroglioma at the glioblastoma suppressor locus on chromosome 10q25-26. Maier D; Comparone D; Taylor E; Zhang Z; Gratzl O; Van Meir EG; Scott RJ; Merlo A Oncogene; 1997 Aug; 15(8):997-1000. PubMed ID: 9285695 [TBL] [Abstract][Full Text] [Related]
58. DMBT1 homozygous deletion in diffuse astrocytomas is associated with unfavorable clinical outcome. Motomura K; Mittelbronn M; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Nakazato Y; Tanaka Y; Pierscianek D; Kim YH; Mariani L; Vital A; Ohgaki H J Neuropathol Exp Neurol; 2012 Aug; 71(8):702-7. PubMed ID: 22805772 [TBL] [Abstract][Full Text] [Related]
59. Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma. Hartmann C; Nümann A; Mueller W; Holtkamp N; Simon M; von Deimling A Int J Cancer; 2004 Mar; 108(6):839-44. PubMed ID: 14712485 [TBL] [Abstract][Full Text] [Related]
60. PTEN/MMAC1 mutations in endometrial cancers. Risinger JI; Hayes AK; Berchuck A; Barrett JC Cancer Res; 1997 Nov; 57(21):4736-8. PubMed ID: 9354433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]